Inventor · disambiguated record
Ursula A. Germann
Also filed as: GERMANN URSULA · GERMANN URSULA A
10 granted patents·4 pending applications·324 citations·filing 1998–2018
92Inventor score
Top patents by PatentIndex Score
14 records- 0196US9518056B2Inhibitors of influenza viruses replicationVERTEX PHARMA·Filed 2015·Granted Dec 13, 2016·16 cites·4 claims
- 0295US8829007B2Inhibitors of influenza viruses replicationVERTEX PHARMA·Filed 2013·Granted Sep 9, 2014·28 cites·2 claims
- 0394US9808459B2Inhibitors of influenza viruses replicationVERTEX PHARMA·Filed 2016·Granted Nov 7, 2017·11 cites·8 claims
- 0494US9345708B2Inhibitors of influenza viruses replicationVERTEX PHARMA·Filed 2014·Granted May 24, 2016·21 cites·16 claims
- 0592US10039762B2Inhibitors of influenza viruses replicationVERTEX PHARMA·Filed 2017·Granted Aug 7, 2018·7 cites·2 claims
- 0691US6162613AMethods for designing inhibitors of serine/threonine-kinases and tyrosine kinasesVERTEX PHARMA·Filed 1998·Granted Dec 19, 2000·95 cites·9 claims
- 0788US6528276B1Fusion proteins, DNA molecules, vectors, and host cells useful for measuring protease activityVERTEX PHARMA·Filed 2000·Granted Mar 4, 2003·29 cites·15 claims
- 0885US6117639AFusion proteins, DNA molecules, vectors, and host cells useful for measuring protease activityVERTEX PHARMA·Filed 1998·Granted Sep 12, 2000·110 cites·13 claims
- 0972US6849716B1Methods for designing inhibitors of serine/threonine kinases and tyrosine kinasesVERTEX PHARMA·Filed 2000·Granted Feb 1, 2005·7 cites·2 claims
- 1068US10874673B2Inhibitors of influenza viruses replicationVERTEX PHARMA·Filed 2018·Granted Dec 29, 2020·0 cites·30 claims
- 1163US2004259166A1Methods for designing inhibitors of serine/threonine kinases and tyrosine kinasesFiled 2004·Application pending·0 cites
- 1258US2003083467A1Fusion proteins, DNA molecules, vectors, and host cells useful for measuring protease activityFiled 2002·Application pending·0 cites
- 1355US2012171245A1Inhibitors of influenza viruses replicationCHARIFSON PAUL S·Filed 2011·Application pending·0 cites
- 1449US2003165899A1Methods for designing inhibitors of serine/threonine kinases and tyrosine kinasesVERTEX PHARMA·Filed 2002·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →